Cubist Systematic Strategies’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-17,738
Closed -$216K – 3745
2024
Q1
$216K Buy
17,738
+9,559
+117% +$139K ﹤0.01% 3042
2023
Q4
$117K Buy
+8,179
New +$78.5K ﹤0.01% 3150
2023
Q3
– Sell
-40,276
Closed -$576K – 3773
2023
Q2
$576K Sell
40,276
-53,746
-57% -$765K ﹤0.01% 2305
2023
Q1
$1.38M Buy
94,022
+24,564
+35% +$411K 0.01% 1939
2022
Q4
$1.17M Buy
69,458
+31,542
+83% +$545K 0.01% 2295
2022
Q3
$562K Buy
37,916
+3,186
+9% +$63K ﹤0.01% 3069
2022
Q2
$951K Buy
34,730
+8,794
+34% +$261K 0.01% 2521
2022
Q1
$978K Buy
25,936
+5,390
+26% +$239K 0.01% 2039
2021
Q4
$1.28M Buy
20,546
+1,289
+7% +$97.7K 0.01% 1732
2021
Q3
$1.65M Buy
19,257
+12,070
+168% +$757K 0.02% 1165
2021
Q2
$445K Buy
7,187
+903
+14% +$46K 0.01% 2085
2021
Q1
$306K Buy
+6,284
New +$303K ﹤0.01% 2241

Other funds holding OPRX

Cubist Systematic Strategies's OPRX Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 17,738 shares — an estimated $216K sold.

Cubist Systematic Strategies first reported a position in OPRX in Q1 2021 and held it in 12 quarters. The position peaked at $1.65M in Q3 2021. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 17,738 OptimizeRx shares in Q2 2024, an estimated $216K.
  • Cubist Systematic Strategies first reported a position in OptimizeRx in Q1 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's OptimizeRx position peaked at $1.65M in Q3 2021.
  • 92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.